News Focus
News Focus
icon url

wrinklesobw

05/27/23 12:36 AM

#162000 RE: LonghornSean #161999

He’s not worried about the individual investors, especially investors in the otc. All he cares about is getting approval and he will do it with or without the otc.
icon url

SC8

05/27/23 4:23 AM

#162003 RE: LonghornSean #161999

Not a surprise.

About 6 cents atm for flea farts of RDGL is what one should expect after an offering for more than 5% of company at $0.078. That combined with RDGL being an FDA play still messing with animals, makes about 6 cents a fair price vs. the risk. In short, everything about RDGL is moot without IDE approval for human trials, and at moment, there's no end in sight to RDGL getting around to submitting an IDE application for FDA consideration..

Getting on 21 months now since MK said RDGL would submit Radiogel IDE application, and here we are still waiting. Sure wish the guy would focus.
icon url

konshe

05/27/23 10:57 PM

#162008 RE: LonghornSean #161999

You means $2.5 a share to take your profis?
Bullish
Bullish
icon url

splintered sunlight

05/29/23 8:25 PM

#162016 RE: LonghornSean #161999

There is an endless supply it seems.